Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease

Elliott J. Mufson, Joanne Wuu, Scott E. Counts, Anders Nykjaer

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The nerve growth factor (NGF) precursor protein proNGF is the predominant NGF moiety found in the human neocortex and exhibits pro-apoptotic properties when bound to the p75NTR neurotrophin receptor in the presence of sortilin, a Vps10p domain trafficking protein. Recently studies have shown that proNGF levels increase in the cortex of people who died with early stage Alzheimer's disease (AD) or with mild cognitive impairment (MCI), a putative prodromal AD stage. In contrast, cortical levels of the high-affinity, pro-survival NGF receptor TrkA are reduced in AD despite stable levels of p75NTR. These data suggest a stoichiometric shift in proNGF and its receptors which favors proNGF binding of p75NTR. Whether cortical levels of sortilin are altered during the progression of AD remains unknown. Therefore, we measured sortilin protein levels in postmortem superior frontal and superior temporal cortical tissues derived from Religious Orders Study subjects clinically diagnosed antemortem with no cognitive impairment (NCI), MCI or AD. No changes in frontal or temporal cortical sortilin protein levels occurred across the clinical groups. There was no association between sortilin levels and antemortem cognitive test scores. However, there was a positive association between temporal cortex sortilin levels and severity of neuropathology by Braak and NIA-Reagan diagnoses. The stability of cortical sortilin levels in the face of stable p75NTR, increased proNGF, and reduced TrkA levels may favor pro-apoptotic proNGF:p75NTR:sortilin trimeric interactions within the cortex during the earliest stages of AD. These findings are relevant to the development of NGF drug therapy for the treatment of dementia.

Original languageEnglish
Pages (from-to)129-133
Number of pages5
JournalNeuroscience Letters
Volume471
Issue number3
DOIs
StatePublished - Mar 8 2010
Externally publishedYes

Fingerprint

Alzheimer Disease
Proteins
Nerve Growth Factor
Nerve Growth Factor Receptors
Nerve Growth Factor Receptor
Protein Precursors
Cognitive Dysfunction
sortilin
Neocortex
Protein Transport
Temporal Lobe
Dementia
Drug Therapy
Survival

Keywords

  • Alzheimer's disease
  • Mild cognitive impairment
  • proNGF
  • Receptors
  • Sortilin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. / Mufson, Elliott J.; Wuu, Joanne; Counts, Scott E.; Nykjaer, Anders.

In: Neuroscience Letters, Vol. 471, No. 3, 08.03.2010, p. 129-133.

Research output: Contribution to journalArticle

Mufson, Elliott J. ; Wuu, Joanne ; Counts, Scott E. ; Nykjaer, Anders. / Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. In: Neuroscience Letters. 2010 ; Vol. 471, No. 3. pp. 129-133.
@article{9354e8f250404c139fd61f9909bd07fc,
title = "Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease",
abstract = "The nerve growth factor (NGF) precursor protein proNGF is the predominant NGF moiety found in the human neocortex and exhibits pro-apoptotic properties when bound to the p75NTR neurotrophin receptor in the presence of sortilin, a Vps10p domain trafficking protein. Recently studies have shown that proNGF levels increase in the cortex of people who died with early stage Alzheimer's disease (AD) or with mild cognitive impairment (MCI), a putative prodromal AD stage. In contrast, cortical levels of the high-affinity, pro-survival NGF receptor TrkA are reduced in AD despite stable levels of p75NTR. These data suggest a stoichiometric shift in proNGF and its receptors which favors proNGF binding of p75NTR. Whether cortical levels of sortilin are altered during the progression of AD remains unknown. Therefore, we measured sortilin protein levels in postmortem superior frontal and superior temporal cortical tissues derived from Religious Orders Study subjects clinically diagnosed antemortem with no cognitive impairment (NCI), MCI or AD. No changes in frontal or temporal cortical sortilin protein levels occurred across the clinical groups. There was no association between sortilin levels and antemortem cognitive test scores. However, there was a positive association between temporal cortex sortilin levels and severity of neuropathology by Braak and NIA-Reagan diagnoses. The stability of cortical sortilin levels in the face of stable p75NTR, increased proNGF, and reduced TrkA levels may favor pro-apoptotic proNGF:p75NTR:sortilin trimeric interactions within the cortex during the earliest stages of AD. These findings are relevant to the development of NGF drug therapy for the treatment of dementia.",
keywords = "Alzheimer's disease, Mild cognitive impairment, proNGF, Receptors, Sortilin",
author = "Mufson, {Elliott J.} and Joanne Wuu and Counts, {Scott E.} and Anders Nykjaer",
year = "2010",
month = "3",
day = "8",
doi = "10.1016/j.neulet.2010.01.023",
language = "English",
volume = "471",
pages = "129--133",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease

AU - Mufson, Elliott J.

AU - Wuu, Joanne

AU - Counts, Scott E.

AU - Nykjaer, Anders

PY - 2010/3/8

Y1 - 2010/3/8

N2 - The nerve growth factor (NGF) precursor protein proNGF is the predominant NGF moiety found in the human neocortex and exhibits pro-apoptotic properties when bound to the p75NTR neurotrophin receptor in the presence of sortilin, a Vps10p domain trafficking protein. Recently studies have shown that proNGF levels increase in the cortex of people who died with early stage Alzheimer's disease (AD) or with mild cognitive impairment (MCI), a putative prodromal AD stage. In contrast, cortical levels of the high-affinity, pro-survival NGF receptor TrkA are reduced in AD despite stable levels of p75NTR. These data suggest a stoichiometric shift in proNGF and its receptors which favors proNGF binding of p75NTR. Whether cortical levels of sortilin are altered during the progression of AD remains unknown. Therefore, we measured sortilin protein levels in postmortem superior frontal and superior temporal cortical tissues derived from Religious Orders Study subjects clinically diagnosed antemortem with no cognitive impairment (NCI), MCI or AD. No changes in frontal or temporal cortical sortilin protein levels occurred across the clinical groups. There was no association between sortilin levels and antemortem cognitive test scores. However, there was a positive association between temporal cortex sortilin levels and severity of neuropathology by Braak and NIA-Reagan diagnoses. The stability of cortical sortilin levels in the face of stable p75NTR, increased proNGF, and reduced TrkA levels may favor pro-apoptotic proNGF:p75NTR:sortilin trimeric interactions within the cortex during the earliest stages of AD. These findings are relevant to the development of NGF drug therapy for the treatment of dementia.

AB - The nerve growth factor (NGF) precursor protein proNGF is the predominant NGF moiety found in the human neocortex and exhibits pro-apoptotic properties when bound to the p75NTR neurotrophin receptor in the presence of sortilin, a Vps10p domain trafficking protein. Recently studies have shown that proNGF levels increase in the cortex of people who died with early stage Alzheimer's disease (AD) or with mild cognitive impairment (MCI), a putative prodromal AD stage. In contrast, cortical levels of the high-affinity, pro-survival NGF receptor TrkA are reduced in AD despite stable levels of p75NTR. These data suggest a stoichiometric shift in proNGF and its receptors which favors proNGF binding of p75NTR. Whether cortical levels of sortilin are altered during the progression of AD remains unknown. Therefore, we measured sortilin protein levels in postmortem superior frontal and superior temporal cortical tissues derived from Religious Orders Study subjects clinically diagnosed antemortem with no cognitive impairment (NCI), MCI or AD. No changes in frontal or temporal cortical sortilin protein levels occurred across the clinical groups. There was no association between sortilin levels and antemortem cognitive test scores. However, there was a positive association between temporal cortex sortilin levels and severity of neuropathology by Braak and NIA-Reagan diagnoses. The stability of cortical sortilin levels in the face of stable p75NTR, increased proNGF, and reduced TrkA levels may favor pro-apoptotic proNGF:p75NTR:sortilin trimeric interactions within the cortex during the earliest stages of AD. These findings are relevant to the development of NGF drug therapy for the treatment of dementia.

KW - Alzheimer's disease

KW - Mild cognitive impairment

KW - proNGF

KW - Receptors

KW - Sortilin

UR - http://www.scopus.com/inward/record.url?scp=76849093311&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76849093311&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2010.01.023

DO - 10.1016/j.neulet.2010.01.023

M3 - Article

VL - 471

SP - 129

EP - 133

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -